Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Obicetrapib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NewAmsterdam Pharma Presents 3 Abstracts at 2026 ACC
    NewAmsterdam Pharma Presents 3 Abstracts at 2026 ACC

    23 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/23/3260336/0/en/NewAmsterdam-Pharma-Announces-Three-Presentations-at-the-2026-American-College-of-Cardiology-Annual-Scientific-Session.html

    GLOBENEWSWIRE
    23 Mar 2026
    Share Share
    NewAmsterdam Pharma Unveils 2025 Financials And Corporate Update
    NewAmsterdam Pharma Unveils 2025 Financials And Corporate Update

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240069/0/en/NewAmsterdam-Pharma-Reports-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Newamsterdam Pharma Showcases 2025 Successes, Sets 2026 Goals
    Newamsterdam Pharma Showcases 2025 Successes, Sets 2026 Goals

    09 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/09/3216046/0/en/NewAmsterdam-Pharma-Highlights-2025-Achievements-and-Outlines-2026-Strategic-Priorities.html

    GLOBENEWSWIRE
    09 Jan 2026
    Share Share
    Leading Pharma Selects Caristo For Global Imaging Core Lab
    Leading Pharma Selects Caristo For Global Imaging Core Lab

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/caristo-chosen-by-leading-pharma-company-as-worldwide-imaging-core-lab-to-measure-coronary-plaque-and-inflammation-302583106.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share
    Menarini Group Submits Obicetrapib Applications to EMA for Review
    Menarini Group Submits Obicetrapib Applications to EMA for Review

    02 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/menarini-groups-obicetrapib-and-obicetrapibezetimibe-marketing-authorisation-applications-accepted-for-review-by-the-european-medicines-agency-ema-for-the-treatment-of-adults-with-primary-hypercholesterolaemia-heterozygous-fa-302543737.html

    PR NEWSWIRE
    02 Sep 2025
    Share Share
    NewAmsterdam Submits Obicetrapib for Ema Review
    NewAmsterdam Submits Obicetrapib for Ema Review

    18 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/18/3134956/0/en/NewAmsterdam-Announces-Acceptance-of-Marketing-Authorization-Applications-for-Review-by-European-Medicine-Agency-for-Obicetrapib.html

    GLOBENEWSWIRE
    18 Aug 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.